Venetoclax, Cladribine Plus Low-Dose Cytarabine Achieved High Remission in Patients with Relapse/Refractory Acute Leukemia: Preliminary Results of a Phase II Study
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:3212-3213 - Subject
- Language
- ISSN
- 0006-4971